Twinaqt Tablet HIV

Product Description

Twinaqt 50/300 Tablet contains Dolutegravir and Lamivudine. Both Dolutegravir and Lamivudine are nucleoside reverse transcriptase inhibitors. Twinaqt 50/300 Tablet works by interfering with the working of nucleotide and nucleoside reverse transcriptase enzymes necessary for virus reproduction. Together, Twinaqt 50/300 Tablet helps treat HIV infections.

Twinaqt 50/300 Tablet is a prescription medication. You should take this medicine exactly as prescribed by the doctor. The common side effects of Twinaqt 50/300 Tablet are nausea, headache, tiredness, diarrhoea, dizziness, anxiety, gas, difficulty falling asleep or staying asleep and muscle weakness. Most of these side effects of Twinaqt 50/300 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Twinaqt 50/300 Tablet is not recommended to take Twinaqt 50/300 Tablet if you are allergic to any of its contents. Twinaqt 50/300 Tablet is not recommended for use in children and adolescents under 18 years of age. Twinaqt 50/300 Tablet may cause dizziness, so do not drive or operate heavy machinery if you feel dizzy. Consumption of alcohol may increase the risk of side effects; therefore, avoid alcohol consumption. You should not become pregnant while you are taking Twinaqt 50/300 Tablet . Talk to your doctor about effective birth control methods that you can use during your treatment. If you become pregnant while taking Twinaqt 50/300 Tablet , call your doctor immediately. You should not breastfeed if you are infected with HIV or if you are taking Twinaqt 50/300 Tablet .

Powerful Dual-Action HIV Therapy

Twinaqt Tablet combines Dolutegravir and Lamivudine, two proven antiretroviral agents, to effectively manage HIV-1 infection. The synergistic action of these drugs helps inhibit the virus's replication cycle, reducing viral load and supporting immune function in individuals undergoing treatment.


Convenient Once-Daily Dosage

Designed with patient convenience in mind, Twinaqt Tablet requires just one dose per day, with or without meals, depending upon the healthcare provider's instructions. This simplified dosing regimen helps promote greater adherence and improves overall treatment outcomes.


Safe Storage and Extended Shelf Life

Each HDPE bottle provides 30 tablets and features secure packaging to ensure product integrity. The formulation offers a shelf life of 24 months from the manufacturing date when kept in a cool, dry environment below 30C, protected from direct light and moisture.